CEFTAZIDIME SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ceftazidime Sodium, and when can generic versions of Ceftazidime Sodium launch?
Ceftazidime Sodium is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in CEFTAZIDIME SODIUM is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.
Summary for CEFTAZIDIME SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFTAZIDIME SODIUM at DailyMed |
Recent Clinical Trials for CEFTAZIDIME SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Arrevus Inc. | Phase 2 |
| Zunyi Medical College | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
US Patents and Regulatory Information for CEFTAZIDIME SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-002 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-003 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
